While this rapid evolution toward multi-agonist strategies and oral formulations promises enhanced efficacy, tolerability, and adherence, generating robust long-term safety and efficacy evidence remains imperative
10.1038/s41598-018-20014-y [DOI] [PMC free article] [PubMed] [Google Scholar] 183.Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, et al
Special technology: APLB's proprietary formula ensures the ingredients remain stable and penetrate deeply for maximum effectiveness
Cagrilintide is a long-acting analogue of amylin a naturally occurring hormone produced by the pancreas developed by Danish pharmaceutical company Novo Nordisk
5a and Supplementary Dataset 3)
Several reported concerns about its potential toxicity exist, especially if GO nanoparticles are small enough to be inhaled into the lungs 324